Publications by authors named "Israel Robert"

Claim this Profile
C
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia.
Giulia Morsica, Emanuela Messina, Sabrina Bagaglio, Laura Galli, Riccardo Lolatto, Robert J Israel

Microorganisms· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermal Granuloma Annulare After SARS-CoV-2 Vaccination: A Rare Complication.
Muhammad Tahir, Belin F Bodies, Sara Shalin, Thuy Phung, Thomas C Myers, Robert Israel

Cureus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness.
Neel Mehta, Neal E Slatkin, Robert J Israel, Nancy Stambler, Eric D Shah

J Pain Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose.
Bruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, Nancy Stambler, Robert J Israel

J Pain Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials.
Jasmohan S Bajaj, Tarek I Hassanein, Nikolaos T Pyrsopoulos, Arun J Sanyal, Robert S Rahimi, Robert J Israel

Clin Gastroenterol Hepatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis.
Lynn R Webster, Darren Brenner, Robert J Israel, Nancy Stambler, Neal E Slatkin

Pain Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy Volunteers.
Jimin Lee, Robert Lester, Terry O'Reilly, Ezra R Lowe, Neal E Slatkin, Robert J Israel

Clin Pharmacol Drug Dev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials.
Eric D Shah, Bruce H Chamberlain, Michelle Rhiner, Neil E Slatkin, Nancy Stambler, Robert J Israel

J Pain Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial.
Garyfallia Poulakou, Maxime Barakat, Robert J Israel, Marcelo R Bacci,

Clin Transl Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation.
David Farchadi, Neal E Slatkin, Nancy Stambler, Robert J Israel, Michael Matus

Curr Ther Res Clin Exp· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin.
Peter Couroux, Alexandre Brkovic, Jason L Vittitow, Robert J Israel, Chinna Pamidi

Clin Transl Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
W Frank Peacock, Neal E Slatkin, Robert J Israel, Nancy Stambler

J Emerg Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series.
Emanuela Messina, Anna Danise, Giulio Ferrari, Andrea Andolina, Matteo Chiurlo, Robert J Israel

Infect Dis Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P029 Pharmacokinetic/Pharmacodynamic Analysis of Amiselimod, a Selective Sphingosine 1-Phosphate Receptor Modulator, in Healthy Subjects: Results From a Phase 1 Study.
Jimin Lee, Robert Lester, Terry O'Reilly, Ezra Lowe, Neal Slatkin, Robert Israel

Am J Gastroenterol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
Darren M Brenner, Neal E Slatkin, Nancy Stambler, Robert J Israel, Paul H Coluzzi

Support Care Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies.
Bruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, Nancy Stambler, Robert J Israel

J Pain Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials.
Neel Mehta, Neal E Slatkin, Robert J Israel, Nancy Stambler

F1000Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P014 Analysis of QT Interval Prolongation of Amiselimod in Healthy Subjects: A Phase 1 Randomized Controlled Trial.
Hanauer Stephen, O'Reilly Terry, Lester Robert, Slatkin Neal, Lee Jimin, Israel Robert

Am J Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancy Rates in Brodalumab Clinical Studies for Psoriasis.
Alice Gottlieb, Mark Lebwohl, Clive Liu, Robert J Israel, Abby Jacobson

Am J Clin Dermatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer.
Bruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, Nancy Stambler, Robert J Israel

Pain Manag· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and skin clearance recapture in clinical studies of brodalumab.
Jerry Bagel, Mark Lebwohl, Robert J Israel, Abby Jacobson

J Am Acad Dermatol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Daniel P Petrylak, Nicholas J Vogelzang, Kamal Chatta, Mark T Fleming, David C Smith, Robert J Israel

Prostate· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study.
Mark G Lebwohl, Andrew Blauvelt, Alan Menter, Kim A Papp, Scott Guenthner, Robert J Israel

Am J Clin Dermatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials.
Mark G. Lebwohl, Jeffrey L. Sugarman, Linda Stein Gold, Tina Lin, Robert Israel

J Drugs Dermatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.
Daniel P Petrylak, Philip Kantoff, Nicholas J Vogelzang, Anthony Mega, Mark T Fleming, Robert Dreicer, Robert J Israel

Prostate· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis